See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
09:06am, Monday, Aug 04, 2025
Mural Oncology Reports Q2 2025 Financial Loss and Strategic Shift Following Product Discontinuation
Mural Oncology plc (NASDAQ: MURA) has reported its quarterly financial performance for the period ending June 30, 2025, highlighting both challenges and strategic decisions following the discontinuation of its lead product candidate, nemvaleukin. Key Financial Highlights: Net Loss: $47.98 millio...
Read More